T

Thor Medical ASA
OSE:TRMED

Watchlist Manager
Thor Medical ASA
OSE:TRMED
Watchlist
Price: 2.835 NOK 10.74% Market Closed
Market Cap: 665.8m NOK
Have any thoughts about
Thor Medical ASA?
Write Note

P/E
Price to Earnings

-16.8
Current
-2.7
Median
22.7
Industry
Lower than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-16.8
=
Market Cap
665.8m NOK
/
Net Income
-39.6m NOK
All Countries
Close
Market Cap P/E
NO
Thor Medical ASA
OSE:TRMED
665.8m NOK -16.8
FR
Pharnext SCA
OTC:PNEXF
6T USD -179 646.3
US
Abbvie Inc
NYSE:ABBV
325.5B USD 64
US
Amgen Inc
NASDAQ:AMGN
150.4B USD 35.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.9B USD -251.7
US
Gilead Sciences Inc
NASDAQ:GILD
115.7B USD 917.8
US
Epizyme Inc
F:EPE
94.1B EUR -475.6
AU
CSL Ltd
ASX:CSL
135.7B AUD 33.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
83.7B USD 18
US
Seagen Inc
F:SGT
39.3B EUR -55.1
NL
argenx SE
XBRU:ARGX
34.6B EUR -131
Earnings Growth
NO
T
Thor Medical ASA
OSE:TRMED
Average P/E: 213.7
Negative Multiple: -16.8
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -179 646.3 N/A
US
Abbvie Inc
NYSE:ABBV
64
412%
US
Amgen Inc
NASDAQ:AMGN
35.6
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -251.7
42%
US
Gilead Sciences Inc
NASDAQ:GILD
917.8
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -475.6 N/A
AU
CSL Ltd
ASX:CSL
33.2
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.1 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -131 N/A

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
-5.6
2-Years Forward
P/E
N/A
3-Years Forward
P/E
N/A

See Also

Discover More